Skip to content
Open access

Lynch syndrome associated with the pathogenic MSH2 p.A230Lfs*16 variant presenting with sequential colorectal, endometrial, and ampullary cancers: a case report

Oct 2026 · Frontiers in Oncology · 0 citations · 19 references

TL;DR

A rare Lynch syndrome patient carrying a known pathogenic germline variant complicated with sequential colorectal, endometrial and ampullary carcinoma is reported, emphasizing the importance of early LS screening and lifelong surveillance for individuals with multiple primary malignancies.

Abstract

Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer, is one of the most prevalent hereditary tumor syndromes. Its primary pathogenic mechanism lies in germline mutations of DNA mismatch repair (MMR) genes, which trigger genomic instability and substantially elevate the risk of malignant transformation in multiple organs. The hallmark clinical manifestations of LS include early-onset malignancies, multiple synchronous or metachronous primary neoplasms, distinct familial hereditary predisposition, as well as characteristic molecular phenotypes of tumors such as high microsatellite instability (MSI-H) and loss of MMR protein expression. The patient was diagnosed with moderately differentiated transverse colon adenocarcinoma with mucinous components in June 2015. In December 2015, endometrial malignant transformation arising from endometrial polyps was confirmed. The patient developed hypertension around 2021, with blood pressure controlled by oral amlodipine besylate. Cerebral thrombosis was identified in 2023, followed by symptomatic supportive treatment. In May 2026, ampullary carcinoma was newly diagnosed. Germline genetic testing revealed a frameshift variant MSH2 p.A230Lfs * 16, confirming the diagnosis of LS. According to the patient’s self-report, her nephew was also diagnosed with LS via genetic testing, but this diagnosis could not be independently verified. This case documents an unusual clinical course of three sequential primary malignancies in a carrier of the known pathogenic MSH2 p.A230Lfs * 16 germline variant. For patients with multiple primary neoplasms and a positive family history of malignant tumors, early LS screening is recommended. Lifelong comprehensive tumor surveillance should be conducted among LS patients to enable early diagnosis and prompt treatment, ultimately prolonging patient survival. We report a rare Lynch syndrome patient carrying a known pathogenic germline MSH2 p.A230Lfs * 16 variant complicated with sequential colorectal, endometrial and ampullary carcinoma. The patient received radical surgeries and adjuvant chemotherapy, with dual immunotherapy planned for ampullary cancer. According to the patient’s self-report, her nephew was also diagnosed with LS, but this diagnosis has not been independently verified. This case provides an additional phenotypic observation of this known pathogenic frameshift variant, and it should be noted that a single case report cannot establish or expand the variant-specific tumor susceptibility spectrum. This report emphasizes the importance of early LS screening and lifelong surveillance for individuals with multiple primary malignancies.

Read PDF

Similar papers

Case report Open access Oct 2026

Case Report: Metachronous multiple primary neoplasms in a carrier of germline MSH2 c.958dupA Lynch syndrome

Introduction Lynch syndrome is an autosomal dominant hereditary cancer syndrome caused by germline mutations in DNA mismatch repair (MMR) genes, conferring elevated risks of colorectal, endometrial, gastric, ovarian and other malignancies. We report a 38-year-old woman with a germline MSH2 c.958dupA (p.Thr320Asnfs*13)...

Li-Qiong Wang, Ping Li, Duan-Lin Hu et al. · 0 citations
Open access Sep 2026

Lynch Syndrome in a Young Male Patient: A Rare Case Report with Diagnostic Considerations

Introduction: Lynch syndrome, (LS), or hereditary nonpolyposis colorectal cancer (HNPCC), is an autosomal dominant inherited cancer syndrome primarily caused by germline mutations in DNA mismatch repair (MMR) genes, particularly MLH1 and MSH2. These mutations cause microsatellite instability (MSI), a hallmark of LS-ass...

A. D. Farista, Vidi Orba Busro, Suyata Suyata et al. · 0 citations
Case report Open access Oct 2026

Double heterozygous pathogenic germline APC and MSH2 variants in a 16-year-old female diagnosed with colorectal cancer

Germline pathogenic variants (PVs) of the APC gene cause familial adenomatous polyposis (FAP), whereas PVs in DNA mismatch repair (MMR) genes underlie Lynch Syndrome (LS), formerly known as hereditary non polyposis colorectal cancer (HNPCC). The coexistence of both hereditary syndromes in a single individual has been r...

E. Maccaroni, R. Bacalini, A. Lancianese et al. · 0 citations
Case report Open access Oct 2026

Case Report: A germline SDHB c.268C>T (p.Arg90Ter) variant in a family with very-early-onset colorectal neoplasia

Background Very-early-onset colorectal cancer (CRC), particularly when clustered within a family, raises concern for an inherited cancer predisposition. However, the contribution of germline SDHB variants to CRC susceptibility remains uncertain. We report a family in which two sisters developed colorectal carcinoma bef...

Chang Liu, Da-Yang Zhou, Wen-Jing Xu et al. · 0 citations
Case report Open access Sep 2026

Case Report: DICER1 mutation-associated anaplastic sarcoma of the kidney in a child

DICER1 syndrome is a hereditary tumor predisposition syndrome caused by pathogenic germline variants in DICER1 and is characterized by multi-organ susceptibility; sarcomas remain uncommon within this spectrum. We report a 2-year-old girl with anaplastic sarcoma of the kidney (ASK). Molecular testing identified a germli...

M. Li, Guo-Qian He, Xia Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.